MediView XR, Inc.

MediView XR, Inc.

Private
Cleveland, OhioHealthcare & Life Scienceshttps://mediview.com

Last Round

Series A

Oct 6, 2025

Total Funding Raised

$53.4M

Momentum Score

25 /100

Company Overview

MediView XR, Inc. is a med-tech company that provides an augmented reality surgical navigation platform with 3D holographic visualization and remote collaboration capabilities for image-guided medical procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, AR/VR Experiences, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AR surgical navigationmedical augmented realityimage-guided surgerydigital surgeryholographic surgeryX-ray visionsurgical navigationcomputer-assisted surgeryprocedural guidanceimage fusionminimally invasive proceduresinterventional radiologyCT ultrasound fusionmedical deviceFDA 510(k) clearanceremote collaborationtelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MediView XR, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MediView XR, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AOct 6, 2025
StrategicMay 16, 2023
SAFEMar 9, 2022
SeedOct 22, 2019

Key People

Founding team and executive leadership

Adam E. Rakestraw

Cofounder, Chairman, Chief Business Development Officer

Founding Team

Mina Fahim

CEO President

Executive Team

Glenn Raudins

Chief Technology Officer

Executive Team

Tim Hauch

Chief Financial Officer

Executive Team

MediView XR, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    OmnifyXR Interventional Suite highlighted in sales role posting.

  • Mar 1, 2026

    XR90 augmented-reality navigation system is now available.

MediView XR, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MediView XR, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MediView XR, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range52
Year Founded2017
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.